Taking into account the therapeutic potential of reducing PTHLH expression in malignant neuroblastomas, we sought to identify the molecule/s that control its production specifically in this tumoral context, as this would provide a therapeutic opportunity. The gene discussed is PTHLH; the disease is neuroblastoma.